Tibet Weixinkang Medicine (SHG: 603676)

Tibet Weixinkang Medicine is a corporation based in Lhasa, China. Established in 2006, the company is engaged in the research and development, production, and sales of chemical drugs and their bulk drugs. Its core products cover the parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, medicine for the digestive system, and liver disease. The assets are managed by the executive team.